Print Page  |  Close Window

Investor Overview

NASDAQ: XBIT0.0010.88Data provided by Nasdaq.
Minimum 15 minutes delayed.

XBiotech is building on a foundation of remarkable new therapies, innovative approaches to commercialization and a commitment to realizing treatments for unmet medical needs worldwide.

Recent News
04/28/17XBiotech to Provide First Quarter 2017 Business UpdatePrinter Friendly Version
04/20/17XBiotech Announces Outcome of EMA’s Oral Explanation MeetingPrinter Friendly Version
04/10/17XBiotech Announces Additions To Its Scientific Advisory BoardPrinter Friendly Version

Read more »

Upcoming Events
8:30 a.m. ET
Q1 2017 XBiotech Inc Earnings Conference Call

Read more »